Clinical Trial Update: Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia [NA]

View source ↗

Summary

This clinical trial update reports a completed study evaluating Umooze as add-on therapy for Benign Prostatic Hyperplasia. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Umooze

Snippet

Sponsor: Golden Biotechnology Corporation | Conditions: Benign Prostatic Hyperplasia | NA | Status: COMPLETED | Results posted: 2015-12-31